Case analysis · Calls & text messages

Advantage Medical v. Electrostim: A Fax Number on a Prescription Form Is Not a License to Advertise

A medical device seller that sent a pandemic-era marketing fax to a physician practice could not win summary judgment on its consent defense. In Advantage Medical Associates, P.A. v. Electrostim Medical Services, Inc., No. 24-2992 (GC) (JBD) (D.N.J. Sept. 30, 2025), Judge Castner held that a jury must decide whether the fax related to the reason the practice gave the seller its fax number.

By Harrison GevirtzPublished 2 min read
On this page

Background

The defendant sells electrostimulation devices for chronic pain, which require a physician's letter of medical necessity. In 2017, after a physical therapist recommended a device for one of the practice's patients, the defendant sent the practice a pre-filled letter that included the practice's fax number. The physician signed and returned it. Nearly three years later, in March 2020, the defendant faxed the practice and dozens of other providers announcing that it was still operating during the pandemic, offering remote fitting, and listing its product line. The practice filed a class action under the Telephone Consumer Protection Act (TCPA). Discovery was bifurcated, and the parties briefed only the defense of prior express invitation or permission.

The Third Circuit Test

A fax advertisement is not "unsolicited" if sent with the recipient's prior express invitation or permission. Under Physicians Healthsource, Inc. v. Cephalon, Inc., 954 F.3d 615 (3d Cir. 2020), a fax is solicited if the recipient voluntarily provided its fax number to the sender and the fax relates to the reason the number was provided.

The first prong was undisputed. The second was not. It was undisputed that one reason for including the number was so pharmacists and providers could contact the physician with questions about the patient or prescribed treatment. That is a narrow purpose. A mass-circulated pandemic notice, sent after three years of silence, was not a question about that patient or device.

The defendant argued the broader purpose was to facilitate services for patients generally. The physician's testimony could support either reading. Because purpose goes to the heart of whether the fax was related, it was a fact question for the jury.

The court also declined to adopt a "low bar" for relatedness drawn from a pre-Cephalon district court decision. That case involved a prescription-ready message with a brief flu shot note added, which is not comparable to a standalone promotional fax.

No Business Relationship Shortcut

The defendant also argued consent could be inferred from the parties' relationship. Cephalon relied on continued and sustained contact with sales representatives. Here there was a single patient-specific exchange three years earlier. The practice's later conduct, including not objecting and sending another prescription with its fax number days after the fax, was irrelevant because consent must be prior. The court cited Gorss Motels, Inc. v. Lands' End, Inc., 997 F.3d 470 (2d Cir. 2021), on that point and distinguished cases where the recipient had signed agreements to receive affiliate offers.

The statutory established business relationship exception was not before the court under the parties' stipulation.

Practical Implications

For senders. A fax number on a transactional document supports faxes about that transaction. Using it for broadcast marketing invites a jury question.

For recipients. Testimony on why the number was provided can be decisive. A narrow, patient-specific purpose undercuts a consent defense.

For both. The second Cephalon prong is often fact-intensive.

Read the District of New Jersey opinion in Advantage Medical v. Electrostim.

Not legal advice. TCPA.com provides general information, not legal advice, and is not a substitute for the advice of an attorney. Do not rely on it. Verify any action with your own licensed lawyer before you take it. See our Terms of Use.

Primary sources

  1. Memorandum Opinion, Advantage Medical Associates, P.A. v. Electrostim Medical Services, Inc., No. 24-2992 (GC) (JBD) (D.N.J. Sept. 30, 2025)
  2. Physicians Healthsource, Inc. v. Cephalon, Inc., 954 F.3d 615 (3d Cir. 2020)
  3. Gorss Motels, Inc. v. Lands' End, Inc., 997 F.3d 470 (2d Cir. 2021)
  4. Memorandum Opinion, Advantage Medical Associates, P.A. v. Electrostim Medical Services, Inc., No. 24-2992 (GC) (JBD) (D.N.J. Sept. 30, 2025).
Harrison Gevirtz, Chief Strategy Officer of Ringba, Las Vegas, Nevada

About the Author: Harrison Gevirtz

Harrison Gevirtz serves as the Chief Strategy Officer (CSO) of Ringba, a call tracking and pay per call platform, and is based in Las Vegas, Nevada. Harrison Gevirtz is a serial operator in call tracking, call routing and telemarketing operations, and for the past several years he has focused on how federal regulations affect the daily operations of these industries. At TCPA.com, Harrison Gevirtz covers TCPA litigation, Telemarketing Sales Rule (TSR) enforcement, tech support fraud prosecutions and Federal Communications Commission (FCC) rulemaking in a way that's accessible to the non-lawyer executive or compliance manager.

More from Harrison Gevirtz

Topics